Table 1.
Pathway name | Genes | Metabolites |
Signal transduction** | ||
Signaling by GPCR** | 6/4 | 1/16 |
GPCR ligand binding* | 3/3 | 1/13 |
Class A/1 rhodopsin-like receptors* | 1/2 | 0/11 |
GPCR downstream signaling* | 5/3 | 1/9 |
Diseases** | ||
Glycogen storage diseases* | 6/7 | 1/9 |
Metabolic disorders of oxidation enzymes** | 3/6 | 1/33 |
Gene expression** | 6/9 | 1/17 |
Metabolism** | ||
Biological oxidations** | 1/2 | 1/22 |
Metabolism of amino acids, derivatives, and urea cycle** | 2/7 | 1/24 |
Tyrosine metabolism* | 0/3 | 1/7 |
Metabolism of vitamins and cofactors* | 2/1 | 1/8 |
Metabolism of lipids and lipoproteins* | 7/5 | 2/16 |
Protein digestion and absorption** | 2/2 | 1/19 |
Fatty acid, TAG, and ketone metabolism** | 3/2 | 0/10 |
Purine metabolism* | 3/1 | 1/8 |
Transmembrane transport of small molecules** | ||
SLC-mediated transport** | 5/4 | 2/38 |
Transport of glucose/other sugars** | 3/1 | 0/22 |
ABC transporters** | 3/1 | 1/25 |
Pathways were detected as significantly enriched (*P < 0.05; **P < 0.001) in S. trenchii-containing hosts vs. S. minutum-containing hosts when FDR <0.05 and at least three genes or metabolites were present. The numbers of down-regulated/up-regulated genes and metabolites in S. trenchii-colonized hosts are shown. A list of the genes/metabolites in each pathway is provided in Dataset S6.